There have been limited studies that analyzed levels of diagnostic models in CCA, and the results of this study revealed the importance of further investigations into the diagnostic models using AFP, AFP-L3% and PIVKA-II detection in CCA patients, and of assessing the potential of these diagnostic models in the overall diagnosis of liver cancers (HCC and CAA). The gene discussed is AFP; the disease is liver cancer.